EDGAR Filing Documents for 0001132413-09-000017

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0001132413-09-000017

Filing Date

2009-05-28

Accepted

2009-05-28 17:24:20

Documents

Group Members

CATAPULT CAPITAL MANAGEMENT LLCCATAPULT PARTNERS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq	Description	Document	Type	Size
1		acor_sc13d-a1.htm	SC 13D/A	12722810
	Complete submission text file	0001132413-09-000017.txt		12725242

Mailing Address

Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300

ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81801 | Film No.: 09858294
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103

Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100

MILLENCO LLC (Filed by) CIK: 0001132413 (see all company filings)

IRS No.: 133532932 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A